Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Learn how to weight dividend ETFs by income versus growth to tailor risk, cash flow, and long-term growth in your retirement portfolio.
23,884 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Bridgewater Associates tightened its tech exposure in the latest 13F filing, cutting stakes in Microsoft, Meta, and A...
Coinbase stock has fallen sharply this year, yet a cadre of analysts believes a turnaround is possible as the company...
A veteran mortgage executive leaves loanDepot to launch Trust One Financial, a new broker-focused lender backed by Ea...
Eos Energy Enterprises plunged after reporting a Q4 miss and full-year shortfall, erasing over $1B in market value. T...
Explore the 2026 earnings outlook for Quanex (NX) with a clear, investor-friendly analysis. Learn what drives results...
A major stake in Nvidia from a notable Tesla bull underscores confidence in the AI chip leader’s growth trajectory, e...
New wage data in early 2026 shows the payoff from switching jobs is fading. Movers earned roughly 4% in January, whil...
Micron Technology’s shares advanced again as investors eye a $500 billion market-cap milestone, building on a rapid c...
Analysts push a higher target for NVIDIA as demand for Blackwell and Vera Rubin accelerates. The latest guidance sign...
Two quantum computing stocks with upside projections have caught the eye of Wall Street. This guide breaks down why t...
Rishi Sunak pressed corporate leaders to accelerate AI projects, warning that slow adoption could widen gaps between ...